Form 8-K - Current report:
SEC Accession No. 0001193125-25-165466
Filing Date
2025-07-25
Accepted
2025-07-25 16:19:38
Documents
16
Period of Report
2025-07-25
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d65613d8k.htm   iXBRL 8-K 30857
2 EX-1.1 d65613dex11.htm EX-1.1 207579
3 EX-5.1 d65613dex51.htm EX-5.1 6515
4 EX-99.1 d65613dex991.htm EX-99.1 8841
5 EX-99.2 d65613dex992.htm EX-99.2 8931
  Complete submission text file 0001193125-25-165466.txt   448317

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA absi-20250725.xsd EX-101.SCH 2877
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE absi-20250725_lab.xml EX-101.LAB 17978
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE absi-20250725_pre.xml EX-101.PRE 11276
19 EXTRACTED XBRL INSTANCE DOCUMENT d65613d8k_htm.xml XML 3661
Mailing Address 18105 SE MILL PLAIN BLVD VANCOUVER WA 98683
Business Address 18105 SE MILL PLAIN BLVD VANCOUVER WA 98683 (360) 949-1041
Absci Corp (Filer) CIK: 0001672688 (see all company filings)

EIN.: 853383487 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40646 | Film No.: 251151928
SIC: 8731 Services-Commercial Physical & Biological Research
(CF Office: 08 Industrial Applications and Services)